Mosanna is a Swiss Biotech company based in Basel with a commitment to improving patient outcomes and quality of life in high unmet need diseases, applying a precision medicine approach. We carefully select innovative medicines for further development using the best contract research organisations in the specific specialised field. Our first goal is to bring an effective and well tolerated medicinal nasal spray to Metabolic Obstructive Sleep Apnea patients.
Location: Switzerland, Basel-Landschaft, Münchenstein
Employees: 1-10
Total raised: $80M
Founded date: 2022
Investors 3
| Date | Name | Website |
| 09.06.2025 | Forbion | forbion.co... |
| 25.03.2024 | VentureLab | venturelab... |
| - | High-Tech ... | htgf.de |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 10.06.2025 | Series A | $80M | - |
Mentions in press and media 10
| Date | Title | Description |
| 10.06.2025 | Mosanna Therapeutics: A Breath of Fresh Air in Sleep Apnea Treatment | In the realm of healthcare, innovation often emerges from the shadows of necessity. Mosanna Therapeutics, a biotech company based in Redwood City, California, is stepping into the spotlight with a groundbreaking approach to treating obstruc... |
| 10.06.2025 | Mosanna Therapeutics raises USD 80 million to advance sleep apnea nasal spray | Mosanna Therapeutics, the clinical-stage biotech company headquartered in Basel, is pioneering a pharmaceutical solution for sleep apnea patients with MOS118, a nasal spray administered at nighttime that helps restore the body’s natural ai... |
| 09.06.2025 | Mosanna Therapeutics Raises $80M in Series A Funding | David Weber, Ph.D., President and Chief Executive Officer at Mosanna Therapeutics Mosanna Therapeutics, a Redwood City, CA-based biotech company which which specializes in treatments of obstructive sleep apnea (OSA), raised $80M in Series A... |
| 09.06.2025 | EQT Life Sciences Leads USD 80 Million Series A Funding Round in Mosanna Therapeutics to Advance Sleep Apnea Nasal Spray | EQT Life Sciences Leads USD 80 Million Series A Funding Round in Mosanna Therapeutics to Advance Sleep Apnea Nasal Spray Mon, Jun 09, 2025 16:15 CET Report this content Series A Funding will be used to advance Mosanna’s nasal spray therapy ... |
| 19.04.2023 | Ten biotech startups head to Boston | |
| 12.04.2023 | Mosanna Therapeutics Announces a Seed Extension Financing Round to Complete Preparations to Enter the Clinic with MOS-118 in Metabolic Obstructive Sleep Apnea | April 11, 2023 |
| 12.04.2023 | Mosanna Therapeutics Raises Seed Extension Financing | Mosanna Therapeutics, a Basel, Switzerland-based biotech company, raised an undisclosed amount in a Seed Extension financing round. New investors Supermoon Capital and HTGF joined founding investor Forty51 Ventures (leader of the overall ro... |
| 11.04.2023 | Mosanna Therapeutics eyes clinical trials after seed extension | |
| 15.07.2022 | Mosanna Therapeutics completes seed round | |
| - | Mosanna Therapeutics | “Home - Mosanna Therapeutics” |